Searched for
CIPLA DIVIDEND ANNOUNCEMENT
Bonus issues, dividends and more: Reliance Industries, Trent among 20 stocks turning ex-date this weekReliance Industries, Trent, and 18 other stocks are set to turn ex-date this week for corporate actions including dividends and bonus issue...- Mankind, other pharma stocks rally up to 7%; Nifty Pharma scales fresh peak. What lies ahead?Pharma stocks surged on Wednesday, supported by strong earnings and a weakening rupee, even as Sensex and Nifty traded lower. The Nifty Pha...
- NLC India shares rally 18% to fresh record high after Q4 net profit skyrockets 189% YoYNLC India shares rose to a record high on Thursday after the company posted a 189% YoY surge in Q4 net profit to Rs 1,394 crore. Revenue ro...
- Cipla shares rally 8% despite 55% YoY slump in Q4 profit. Why Citi, Nuvama, other brokerages hiked targetCipla shares surged on Thursday, extending gains to nearly 11% in two sessions, after several brokerages turned bullish on the stock despit...
- Cipla Q4 net profit slumps 55% YoY to Rs 555 crore, full-year PAT down 26%Pharma major Cipla announced a significant 55% drop in its net profit for the March quarter. Total income also saw a 3% decrease. For the f...
- Cipla Q4 Results: Profit falls 55% YoY to Rs 555 crore; co declares Rs 13/sh dividendCipla Ltd announced a significant 55% year-on-year drop in its consolidated net profit for the fourth quarter, reaching Rs 555 crore. This ...
- Stocks in news: Airtel, Tata Motors, Dr Reddy's, NTPC, Dixon TechnologiesMarkets faced selling pressure on Tuesday due to weak global cues and macroeconomic concerns, with the Nifty approaching support at 23,150....
- Q4 earnings, crude oil, FII action among 8 factors to steer D-Street this weekIndian stock markets are set for a busy week. Key events like Q4 earnings announcements for many companies will influence trading. Foreign ...
- Cohance Lifesciences shares rocket 43% in just 2 trading sessions. Here’s what is fuelling the surgeCohance Lifesciences shares surged over 43% in two days following the appointment of former Cipla CEO Umang Vohra as Executive Chairman and...
- HDFC Bank, 2 Bajaj cos approach record date for dividend. Last day to qualify?Several company stocks, including HDFC Bank and Bajaj Finserv, will trade ex-dividend starting Friday. June 26 is the last day to buy these...
- Donald Trump’s order to lower prices may benefit generics, says Cipla CEOCipla anticipates that Donald Trump's order to lower US drug prices could favor generic drug companies like itself. The company reported a ...
- Cipla Q4 Results: Net profit rises 30% YoY to Rs 1,222 crore, revenue up 8.5%Cipla Q4 Results: The company’s revenue from operations grew by 8.45% year-on-year to Rs 6,597.72 crore, compared to Rs 6,082.37 crore in t...
- Stocks in news: Tata Motors, Bank of Baroda, Cipla, BPCL, Manappuram FinanceState-run BPCL on Thursday posted a 35% drop in its standalone net profit at Rs 4,224 crore in the fourth quarter, compared with Rs 6,478 c...
- Stocks in news: RIL, Jio Financial, JSW Infra, Cipla, Gujarat GasReliance Industries Ltd will announce its March quarter results on April 22. Along with the quarterly numbers, the company's board will als...
- Corporate Radar: Clean Science to turn ex-dividend; HDFC, Sun Pharma Q1 results; Biocon, DRL AGMs & moreShares of ABM Knowledgeware (Rs 1.25 per share), MRF (Rs 144 per share), Praj Industries (Rs 2.7 per share), Hawkins Cookers (Rs 60 per sha...
- Corporate Radar: Q4 results, AGMs, dividends, preferential issues & moreAjanta Pharma board would consider bonus issue while disclosing its March quarter results.
- Cipla set to buy 51% of S Africa's Cipla Medpro for about $220 millionCipla said on Wednesday it will buy 51% of Cipla Medpro for about $220 million, valuing the beleaguered South African company at about $440...
- Cipla looks to acquire 25% stake in South African coCipla said it could take a decision to buy stake of up to 25 per cent in South Africa-based, Cipla Medpro in next board meeting. Cipla Medp...
- Cipla gets board nod to buy Meditab for Rs133 crDrug major Cipla said it would acquire domestic pharma company Meditab Specialties for Rs133.35 croRs and it also announced a special divid...
- Weak cash flow may be a drain on CiplaCipla - the leader in the domestic pharmaceutical market - has announced plans to raise Rs 1,500 crore by selling securities in the local a...
Load More
